By staff writers
November 28, 2016

Computer-aided detection (CAD) developer iCAD is touting two studies at RSNA 2016 that show CAD's ability to aid in breast cancer detection.

A study by Dr. Richard Benedikt involved 20 radiologists who retrospectively reviewed 240 digital tomosynthesis cases in a multireader, multicase crossover design. He found that the use of iCAD's concurrent CAD system decreased radiologist reading time 29.2% on average without sacrificing performance compared with reading results without CAD.

The second study by Dr. Corinne Balleyguier involved six radiologists who read 80 digital breast tomosynthesis cases. Results of the pilot study showed that the use of the concurrent iCAD system decreased radiologist reading time 23.5% on average without sacrificing performance, as compared with reading without CAD.

iCAD taps new CFO
Computer-aided detection developer iCAD has hired Richard Christopher as executive vice president and chief financial officer (CFO), effective December...
iCAD touts brachytherapy research at ASTRO 2016
At the American Society for Radiation Oncology (ASTRO) meeting, iCAD is touting clinical data supporting the use of its Xoft Axxent electronic brachytherapy...
iCAD president resigns
Computer-aided detection developer iCAD announced that Kevin Burns, the company's president, chief financial officer, and chief operating officer, is...
iCAD shows revenue decline in Q2
Double-digit growth in product sales was not enough to offset a significant decline in service revenue for computer-aided detection (CAD) developer iCAD...
iCAD adds to customer base
Computer-aided detection developer iCAD recently installed its iReveal automated breast density software at several sites across the U.S.

Copyright © 2016